Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kexin Bicheng Medical Technology is a leading Chinese pharmaceutical R&D organization specializing in advanced drug delivery systems (DDS) and high-end formulation development. Founded in 2003, the company has established itself as a pioneer in the consistency evaluation of generic drugs and the development of specialized pediatric medicines. Their technology portfolio includes proprietary platforms for orally disintegrating tablets (ODT), sustained-release formulations, and taste-masking techniques designed to improve patient compliance. Kexin Bicheng provides comprehensive CRO and CDMO services, supporting the entire drug development lifecycle from pre-clinical formulation to industrial-scale production. The company maintains a robust pipeline of improved formulations (505(b)(2) style) and high-barrier generics across multiple therapeutic areas, including cardiovascular, neurology, and gastroenterology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京科信必成.